Search results
Financial Symmetry Inc Takes $207,000 Position in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 5 hours agoFinancial Symmetry Inc bought a new stake in Johnson & Johnson (NYSE:JNJ – Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and ...
Colton Groome Financial Advisors LLC Raises Stock Position in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 5 hours agoColton Groome Financial Advisors LLC boosted its position in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 32.6% in the 4th quarter, according to the company in its most recent Form ...
Alvotech Announces Topline Results from a Confirmatory Clinical Study for AVT05, a Proposed...
Benzinga· 1 day agoThe confirmatory clinical safety and efficacy study for AVT05, biosimilar candidate to Simponi® and Simponi Aria® (golimumab), met its primary endpoint in patients with moderate to severe rheumatoid
Phase 3 SELECT-GCA Study of Upadacitinib (RINVOQ®) Showed Positive Results in Patients With Giant...
NBC 17 Raleigh· 7 days ago− Results from the Phase 3 SELECT-GCA study showed 46 percent of patients with giant cell arteritis (GCA) who were treated with upadacitinib (RINVOQ®; 15 mg) with a 26-week steroid taper regimen ...
Takeda Pharmaceutical: A Long-Term Cash Cow
GuruFocus.com via Yahoo Finance· 2 days agoSource: Takeda Pharmaceutical. Conclusion Takeda is one of the leaders in the global gastrointestinal and cancer therapeutics markets, which is...
Sandoz confirms European Commission approval of Pyzchiva® (ustekinumab), further strengthening...
Morningstar· 3 days agoAd hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Pyzchiva® approved as one of first ustekinumab biosimilars in EuropeEC approval based on robust development program confirming ...
YHB Investment Advisors Inc. Trims Stake in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 6 days agoYHB Investment Advisors Inc. reduced its position in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 6.7% during the 4th quarter, according to its most recent 13F filing with the Securities ...
Galapagos (NASDAQ:GLPG) Receives “Equal Weight” Rating from Morgan Stanley
ETF DAILY NEWS· 1 day agoGalapagos (NASDAQ:GLPG – Get Free Report)‘s stock had its “equal weight” rating reissued by equities research analysts at Morgan Stanley in a research report issued to clients and investors ...